Induction of G2M Arrest by Flavokawain A, a Kava Chalcone, Increases the Responsiveness of HER2-Overexpressing Breast Cancer Cells to Herceptin by Danielle D. Jandial, Lauren S. Krill, Lixia Chen, Chunli Wu, Yu Ke, Jun Xie, Bang H. Hoang, Xiaolin Zi

Subjects: Get full text

Poncirin Impact on Human HER2 Breast Cancer Cells: Inhibiting Proliferation, Metastasis, and Tumor Growth in Mice Potentially through The PI3K/AKT Pathway by Hao Yun, Li Jing, Jinwen Zhou, Yuanwei Liu, Jin Zhang

Subjects: Get full text

Frequency of HER-2 over Expression in the Patients with Breast Cancer after Mastectomy by S kargar, B alavi farzane

Subjects: “…Breast Cancer; HER-2/neu; HER-2 Overexpression…”
Get full text

Purification and In Vitro Evaluation of an Anti-HER2 Affibody-Monomethyl Auristatin E Conjugate in HER2-Positive Cancer Cells by Isabella Damiani, Silvia Castiglioni, Alicja Sochaj-Gregorczyk, Fabrizia Bonacina, Irma Colombo, Valentina Rusconi, Jacek Otlewski, Alberto Corsini, Stefano Bellosta

Subjects: Get full text

Current therapeutic strategies of anti-HER2 treatment in advanced breast cancer patients by Joanna Huszno, Elżbieta Nowara

Subjects: Get full text

Molecular subtypes predict second breast events of ductal carcinoma in situ after breast‐conserving surgery by Yilan Yang, Xu Zhao, Xuanyi Wang, Kairui Jin, Jurui Luo, Zhaozhi Yang, Xin Mei, Jinli Ma, Zhimin Shao, Zhen Zhang, Xingxing Chen, Xiaomao Guo, Xiaoli Yu

Subjects: Get full text

Risk factors for disease progression in HER2-positive breast cancer patients based on the location of metastases by Joanna Huszno, Elżbieta Nowara

Subjects: Get full text

Targeted inhibition of HER-2 positive breast cancer cells by trastuzumab functionalized pullulan-doxorubicin nanoparticles by Ruiling Xu, Junhui Sui, Mingda Zhao, Yuedi Yang, Lei Tong, Yongmei Liu, Yong Sun, Yujiang Fan, Jie Liang, Xingdong Zhang

Subjects: “…HER-2 overexpression…”
Get full text

Trastuzumab: More than a Guide in HER2-Positive Cancer Nanomedicine by Celia Nieto, Milena A. Vega, Eva M. Martín del Valle

Subjects: “…HER2 overexpression…”
Get full text

Polyethylene glycol-conjugated HER2-targeted peptides as a nuclear imaging probe for HER2-overexpressed gastric cancer detection in vivo by Siao-Syun Guan, Cheng-Tien Wu, Chen-Yuan Chiu, Tsai-Yueh Luo, Jeng-Yih Wu, Tse-Zung Liao, Shing-Hwa Liu

Subjects: Get full text

Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumab by Quentin Jacquinot, Quentin Jacquinot, Nathalie Meneveau, Antoine Falcoz, Malika Bouhaddi, Malika Bouhaddi, Pauline Roux, Bruno Degano, Marion Chatot, Elsa Curtit, Elsa Curtit, Laura Mansi, Laura Mansi, Marie-Justine Paillard, Fernando Bazan, Loïc Chaigneau, Erion Dobi, Guillaume Meynard, Dewi Vernerey, Xavier Pivot, Fabienne Mougin, Fabienne Mougin

Subjects: Get full text

Human Blood Serum Inhibits Ductal Carcinoma Cells BT474 Growth and Modulates Effect of HER2 Inhibition by Dmitrii Kamashev, Nina Shaban, Maria Suntsova, Mikhail Raevskiy, Victor Efimov, Aleksey Moisseev, Maxim Sorokin, Anton Buzdin

Subjects: Get full text

Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin by Emma Zattarin, Federico Nichetti, Francesca Ligorio, Francesca Ligorio, Laura Mazzeo, Riccardo Lobefaro, Giovanni Fucà, Giorgia Peverelli, Andrea Vingiani, Andrea Vingiani, Giulia V. Bianchi, Giuseppe Capri, Filippo de Braud, Filippo de Braud, Claudio Vernieri, Claudio Vernieri

Subjects: Get full text

Application of disitamab vedotin in the multiline treatment of EGFR mutation-positive lung adenocarcinoma with Her-2 overexpression by Meiling Lan, Tianyun Wang, Diexiao Luo, Yan Chen, Wei Liang, Rui Kong, Qichao Xie

Subjects: “…HER-2 overexpression…”
Get full text

Disitamab vedotin, a HER2‐directed antibody‐drug conjugate, in patients with HER2‐overexpression and HER2‐low advanced breast cancer: a phase I/Ib study by Jiayu Wang, Yunjiang Liu, Qingyuan Zhang, Wei Li, Jifeng Feng, Xiaojia Wang, Jianmin Fang, Yiqun Han, Binghe Xu

Subjects: Get full text

A Tetravalent Biparatopic Antibody Causes Strong HER2 Internalization and Inhibits Cellular Proliferation by Filippo Benedetti, Katharina Stadlbauer, Gerhard Stadlmayr, Florian Rüker, Gordana Wozniak-Knopp

Subjects: Get full text

From tissue-specific to tissue-agnostic: HER2 overexpression and the rise of antibody-drug conjugates by Heidi C. Ko, Kyle C. Strickland, Kyle C. Strickland, Dana Jaggessarsingh, Alicia Dillard, Michelle Green, Erin Newburn, Tiffany Sellaro, Jonathan L. Klein, Brian Caveney, Marcia Eisenberg, Eric A. Severson, Shakti Ramkissoon, Shakti Ramkissoon, Rebecca A. Previs, Rebecca A. Previs, Anis Toumeh

Subjects: “…HER2 overexpression…”
Get full text

Potential Advantages of Idarubicin-Loaded Trastuzumab-Coated Liposomes for Combating Head and Neck Squamous Cancer Cells by Marziyeh Ghanemi, Aminollah Pourshohod, Majid Zeinali, Ebrahim Barzegari, Akbar Akbari, Forouzan Absalan, Mostafa Jamalan

Subjects: Get full text

A Comprehensive Review on the Role of Human Epidermal Growth Factor Receptor 2 (HER2) as a Biomarker in Extra-Mammary and Extra-Gastric Cancers by Fnu Amisha, Paras Malik, Prachi Saluja, Nitesh Gautam, Tanvi Harishbhai Patel, Arya Mariam Roy, Sunny R. K. Singh, Sindhu Janarthanam Malapati

Subjects: Get full text

De-escalated radiotherapy for HER2-overexpressing breast cancer patients with 1-3 positive lymph nodes undergoing anti-HER2 targeted therapy by Jing Liu, Jing Liu, Jing Liu, Suning Huang, Zhuofei Bi, Zhuofei Bi, Xiaoxue Zhang, Xiaoxue Zhang, Ziqing He, Ziqing He, Ziqing He, Xiaowen Lan, Xiaowen Lan, Xiaowen Lan, Yuting Tan, Yuting Tan, Xiao Lin, Xiao Lin, Wenyi Zhou, Wenyi Zhou, Xiaobo Huang, Xiaobo Huang, Xiaobo Huang

Subjects: “…HER2 overexpression…”
Get full text